Adendra Therapeutics Ltd.

https://www.adendratx.com

LinkedIn: https://www.linkedin.com/company/adendra-therapeutics

Founded by ATP in 2021 as a spin-out of The Francis Crick Institute, Adendra is an emerging biotechnology company building on new insights into dendritic cell biology to discover and develop new small molecule and biologic medicines for the treatment of a wide range of cancers and autoimmune diseases. *

	Start	2021-08-10 established (s-off)
	Predecessor	Francis Crick Institute Ltd., The
	Industry	BIOTECH
	Person	Mehta, Raj (GammaDelta Therapeutics 201705– Director IP + Alliance Management + Bus Dev before Interim CEO + CRT)

	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	1 Pancras Square The Gridiron Building, Suite 6.05
	City	N1C 4AG London
		Address record changed: 2021-12-08

Basic data	Employees	n. a.

		* Document for »About Section«: Adendra Therapeutics Ltd.. (12/7/21). "Press Release: ATP Launches Adendra Therapeutics, a New Kind of Immunotherapy Company Deploying Novel Insights into Dendritic Cell Biology, with $53M Series A". New York, NY & London.

		Record changed: 2023-07-10

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for Adendra Therapeutics Ltd.

[1] Adendra Therapeutics Ltd.. (12/7/21). "Press Release: ATP Launches Adendra Therapeutics, a New Kind of Immunotherapy Company Deploying Novel Insights into Dendritic Cell Biology, with $53M Series A". New York, NY & London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]